Posttransplant lymphoproliferative disorders and Epstein-Barr virus prophylaxis.
Kuo
P C
PC
Department of Surgery, Stanford University Medical Center, California 94305.
Dafoe
D C
DC
Alfrey
E J
EJ
Sibley
R K
RK
Scandling
J D
JD
D000212:Acyclovir / Q000627:therapeutic use*; D000328:Adult; D015774:Ganciclovir / Q000627:therapeutic use*; D006566:Herpesviridae Infections / Q000209:etiology / Q000517:prevention & control*; D004854:Herpesvirus 4, Human; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D016030:Kidney Transplantation; D008232:Lymphoproliferative Disorders / Q000209:etiology / Q000517:prevention & control*; D008297:Male; D009894:Opportunistic Infections / Q000209:etiology / Q000517:prevention & control*; D017211:Treatment Failure
D007166:Immunosuppressive Agents; D015774:Ganciclovir; D000212:Acyclovir